A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors

NCT06643754 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-3276

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.